New Zealand · Venture startup

Who invested in Advemto

One round we have observed, with the 4 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Manufacturing

Funding summaryUpdated 26 Oct 2026

Undisclosedraised across 1 round since 2025, from 1 source

Latest round
VentureFeb 2025
Investors
4
See who backed them

The rounds

  1. Feb 2025

Founders and team

From Advemto's own website: 1 founder, 1 on the team.

Dr Justin HodgkissChief Executive & Chief Scientific Officer, Founder
  • Dr Alex BarkerChief Technology Officer

Everyone who backed them

Callaghan InnovationInvestment firm1round
Icehouse VenturesVC firm1round
Enterprise AngelsAngel network1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

These 3 firms list Advemto as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.

BoosterVC firmPer its own site
Flying Kiwi AngelsAngel networkPer its own site
BioTools InnovatorAcceleratorPer its own site

Quick answers about Advemto

Who invested in Advemto?

Advemto's investors include Callaghan Innovation, Icehouse Ventures, New Zealand Growth Capital Partners and Enterprise Angels.

How much has Advemto raised?

Advemto has raised 1 round since 2025, none with a disclosed amount.

When did Advemto last raise?

Advemto's most recent round was a Venture in Feb 2025.

Who backed Advemto first?

Advemto's first round on record, in Feb 2025, was backed by Callaghan Innovation, Icehouse Ventures and New Zealand Growth Capital Partners and 1 others.

What stage is Advemto at?

Advemto's latest named round is a Venture, in Feb 2025.

Where is Advemto based?

Advemto is based in New Zealand.

Companies like Advemto

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.